Missing/wrong data? Edit Wikidata item
A phase 1 clinical trial of the sigma-2 receptor complex allosteric antagonist CT1812, a novel therapeutic candidate for Alzheimer's disease
scholarly article by Michael Grundman et al published 2019 in Alzheimer's & dementia (New York, N. Y.)
Author/s
Work details
Publication date:
2019
Language:
English
Country of origin:
Unknown
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.